Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
Anders Olsson(Linköping University), Tomas Leanderson(Lund University), Pascale Plas(Ipsen (France)), Marie Törngren(Active Biotech (Sweden)), Adnan Deronic(Medicon Village), Anette Sundstedt, Valérie Pierron(Ipsen (France)), David Liberg(Active Biotech (Sweden)), Jessica Nakhlé(Ipsen (France)), Luce Bruetschy(Ipsen (France)), Anne-Laure Bauchet(Ipsen (France)), Fabien Schmidlin(Ipsen (France))
Cited by 79
Related Papers
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
|The Lancet|2014|750
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
|Nature Immunology|2003|363
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
|PLoS Biology|2009|358
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
|New England Journal of Medicine|2010|334